References
Harmon DC, Ghori KG, Eustace NP, O’Callaghan SJ, O’Donnell AP, Shorten GD. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study. Can J Anesth 2004; 51: 1002–9.
Michenfelder JD. A valid demonstration of barbiturateinduced brain protection in man-at last. Anesthesiology 1986; 64: 140–2.
Zaidan JR, Klochany A, Martin WM, Ziegler JS, Harless DM, Andrews RB. Effect of thiopental on neurologic outcome following coronary artery bypass grafting. Anesthesiology 1991; 74: 406–11.
Fritz H, Wunderer G. Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung 1983; 33: 479–94.
Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289–91.
Royston D. High-dose aprotinin therapy: a review of the first five years’ experience. J Cardiothorac Vasc Anesth 1992; 6: 76–100.
Murkin JM, Stump DA, Blumenthal JA, McKhann G. Defining dysfunction: group means versus incidence analysis —a statement of consensus. Ann Thorac Surg 1997; 64: 904–5.
Murkin JM. Perioperative neuropsychologic testing (Editorial). J Cardiothorac Vasc Anesth 2001; 15: 1–3.
Kneebone AC, Andrew MJ, Baker RA, Knight JL. Neuropsychologic changes after coronary artery bypass grafting: use of reliable change indices. Ann Thorac Surg 1998; 65: 1320–5.
Heinel LA, Rubin S, Rosenwasser RH, Vasthare US, Turna RF. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull 1994; 34: 137–41.
Brooker RF, Brown WR, Moody DM, et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 1998; 65: 1651–5.
Newman MF, Grocott HP, Mathew JP, et al. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke 2001; 32: 2874–81.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr. Murkin has received independent grant funding from Bayer Pharmaceutical Corp.
Rights and permissions
About this article
Cite this article
Murkin, J.M. Postoperative cognitive dysfunction: aprotinin, bleeding and cognitive testing. Can J Anesth 51, 957–962 (2004). https://doi.org/10.1007/BF03018479
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03018479